News

Changes to the published format of approved medicinal product information

26.09.2022.

Please note that starting from 7 September 2022 the State Agency of Medicines is transitioning to PDF (.pdf) format instead of the previous MS Word (.docx or .doc) format when publishing approved package leaflets...

The 2021 Annual Report of the State Agency of Medicines

30.06.2022.

The State Agency of Medicines has published its Annual Report of the year 2021 which summarizes information regarding the operation of the Agency during the previous year. Some of the numbers that show Agency’s...

Recommendations to clinical trial sponsors on the impact of the war in Ukraine on clinical trials

06.04.2022.

The Clinical Trials Coordination Group (CTCG), set up by the Heads of Medicines Agencies, has developed recommendations for sponsors on the impact of the war in Ukraine on clinical trials. The Latvian Agency of Medicines...

Latest information about Clinical trials information system (CTIS)

17.01.2022.

In the context of the new Clinical Trials Regulation an informative presentation on Clinical Trials Information System (CTIS) has been prepared and is available here.

Survey of the clients and collaboration partners of the State Agency of Medicines

07.01.2022.

Dear clients and collaboration partners of Latvian State Agency of Medicines!

We are truly grateful for our collaboration and provided annual evaluation of accomplished work made by Latvian State Agency of Medicines...

News

Changes to the published format of approved medicinal product information

The 2021 Annual Report of the State Agency of Medicines

Recommendations to clinical trial sponsors on the impact of the war in Ukraine on clinical trials

Latest information about Clinical trials information system (CTIS)

Survey of the clients and collaboration partners of the State Agency of Medicines

Baltic regulatory agencies announce the ePIL project for hospital use medicines

Clinical Trials Information System (CTIS): training programme

The 2020 Annual Report of the State Agency of Medicines

Survey of the clients and collaboration partners of the State Agency of Medicines